Q4 2019 Holdings
Filed 2020-02-14 | 81 holdings | $36.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $10.4M | 318,729 | 28.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $4.9M | 770,538 | 13.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.4M | 418,727 | 12.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $3.9M | 28,100 | 10.7% |
| Alector Inc(ALEC) | COM | 014442107 | $2.5M | 145,000 | 6.8% |
| Accuray Inc(ARAY) | COM | 004397105 | $1.9M | 674,300 | 5.2% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $1.9M | 173,914 | 5.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.8M | 514,051 | 4.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $1.5M | 199,850 | 4.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.3M | 100,000 | 3.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $975.0K | 6,071 | 2.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $831.0K | 100,000 | 2.3% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $72.4K | 13,680,554 | 0.2% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $11.0K | 1,114,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $9.9K | 497,762 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $9.9K | 123,218 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $9.7K | 47,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $9.2K | 470,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $9.0K | 124,806 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.9K | 36,338 | 0.0% |
| Ishares TR Nasdaq Biotech(IBB) | ETF | 464287556 | $7.8K | 64,900 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.6K | 61,008 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $6.5K | 267,839 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $5.6K | 106,749 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $5.3K | 328,533 | 0.0% |
| Luminex Corp | COM | 55027E102 | $4.7K | 204,091 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $4.5K | 98,942 | 0.0% |
| Biohaven Pharmaceuticals Hold(BHVN) | COM | G11196105 | $4.1K | 74,700 | 0.0% |
| Menlo Therapeutics Inc | COM | 586858102 | $3.7K | 797,565 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.4K | $4,000,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.3K | 248,854 | 0.0% |
| Affimed NV | COM | N01045108 | $3.1K | 1,133,559 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $2.6K | 438,884 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $2.6K | 118,314 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.6K | 55,300 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.4K | 173,475 | 0.0% |
| Cardiovascular Systems Inc(CSIIEUR) | COM | 141619106 | $2.2K | 46,200 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $2.2K | 25,500 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $2.2K | 360,542 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $1.9K | 30,408 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $1.8K | 469,135 | 0.0% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $1.8K | 395,772 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $1.7K | 374,423 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.7K | 209,200 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $1.7K | 68,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.6K | 150,000 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $1.6K | 359,190 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $1.6K | 297,300 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $1.6K | 23,000 | 0.0% |
| Eloxx Pharmaceuticals Inc | COM | 29014R103 | $1.5K | 205,825 | 0.0% |